🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The next phase of the COVID-19 pandemic is likely to see a surge in an asso...
Status
Completed
Location
Duke Asthma, Allergy, and Airway Center
Start Date
2021-05-26
Trial ID
NCT04828135
Treatments Being Tested
To evaluate the feasibility of hyperpolarized 129Xe MRI in lung transplant ...
Status
Terminated
Location
Hospital for Sick Chilldren
Start Date
2024-02-07
Trial ID
NCT05550662
Treatments Being Tested
The purpose of this study is to develop and evaluate the usefulness of MRI ...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2011-01
Trial ID
NCT01280994
Treatments Being Tested
This is an observational cohort study building on an existing protocol at o...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2018-07-30
Trial ID
NCT03593434
Treatments Being Tested
In this study the Investigators aim to deploy UTE and HP 129Xe MRI for stru...
Status
Terminated
Location
The Hospital for Sick Children
Start Date
2021-08-05
Trial ID
NCT05014516
Treatments Being Tested
The research is being conducted to develop new imaging methods that are suf...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2020-09-09
Trial ID
NCT03603899
Treatments Being Tested
This study seeks to deploy several forms of 129Xe MRI contrast as well as e...
Status
Completed
Location
Duke University Medical Center
Start Date
2018-03-29
Trial ID
NCT03367312
Treatments Being Tested
In this study, xenon MRI will be used to evaluate regional functional conse...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-11-17
Trial ID
NCT07139899
Treatments Being Tested
This study seeks to deploy several forms of 129Xe MRI contrast as well as e...
Status
Completed
Location
Duke University Medical Center
Start Date
2017-05-03
Trial ID
NCT03078192
Treatments Being Tested